nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—Retinoids—Tretinoin—peripheral nervous system neoplasm	0.217	0.363	CiPCiCtD
Bexarotene—Retinoids—Isotretinoin—peripheral nervous system neoplasm	0.217	0.363	CiPCiCtD
Bexarotene—Retinoids—Alitretinoin—peripheral nervous system neoplasm	0.164	0.275	CiPCiCtD
Bexarotene—RXRG—Isotretinoin—peripheral nervous system neoplasm	0.0553	0.162	CbGbCtD
Bexarotene—RXRA—Isotretinoin—peripheral nervous system neoplasm	0.0489	0.143	CbGbCtD
Bexarotene—RXRB—Isotretinoin—peripheral nervous system neoplasm	0.0489	0.143	CbGbCtD
Bexarotene—RXRG—Alitretinoin—peripheral nervous system neoplasm	0.0342	0.1	CbGbCtD
Bexarotene—RXRG—Tretinoin—peripheral nervous system neoplasm	0.0318	0.0932	CbGbCtD
Bexarotene—RXRB—Alitretinoin—peripheral nervous system neoplasm	0.0302	0.0886	CbGbCtD
Bexarotene—RXRA—Alitretinoin—peripheral nervous system neoplasm	0.0302	0.0886	CbGbCtD
Bexarotene—RXRB—Tretinoin—peripheral nervous system neoplasm	0.0281	0.0824	CbGbCtD
Bexarotene—RXRA—Tretinoin—peripheral nervous system neoplasm	0.0281	0.0824	CbGbCtD
Bexarotene—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00155	0.00454	CbGbCtD
Bexarotene—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.000969	0.00284	CbGbCtD
Bexarotene—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.000901	0.00264	CbGbCtD
Bexarotene—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.000663	0.00195	CbGbCtD
Bexarotene—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000414	0.00121	CbGbCtD
Bexarotene—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000379	0.00111	CbGbCtD
Bexarotene—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000758	CbGbCtD
Bexarotene—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000308	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000308	CcSEcCtD
Bexarotene—Dysuria—Epirubicin—peripheral nervous system neoplasm	1.87e-05	0.000305	CcSEcCtD
Bexarotene—Neutropenia—Epirubicin—peripheral nervous system neoplasm	1.87e-05	0.000305	CcSEcCtD
Bexarotene—Asthenia—Alitretinoin—peripheral nervous system neoplasm	1.87e-05	0.000304	CcSEcCtD
Bexarotene—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	1.87e-05	0.000304	CcSEcCtD
Bexarotene—Influenza—Doxorubicin—peripheral nervous system neoplasm	1.85e-05	0.000302	CcSEcCtD
Bexarotene—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	1.85e-05	0.000302	CcSEcCtD
Bexarotene—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	1.85e-05	0.000301	CcSEcCtD
Bexarotene—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	1.85e-05	0.000301	CcSEcCtD
Bexarotene—Pruritus—Alitretinoin—peripheral nervous system neoplasm	1.84e-05	0.0003	CcSEcCtD
Bexarotene—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	0.000299	CcSEcCtD
Bexarotene—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	1.83e-05	0.000298	CcSEcCtD
Bexarotene—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	1.83e-05	0.000298	CcSEcCtD
Bexarotene—Paraesthesia—Etoposide—peripheral nervous system neoplasm	1.82e-05	0.000297	CcSEcCtD
Bexarotene—Weight increased—Epirubicin—peripheral nervous system neoplasm	1.82e-05	0.000297	CcSEcCtD
Bexarotene—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	0.000296	CcSEcCtD
Bexarotene—Weight decreased—Epirubicin—peripheral nervous system neoplasm	1.81e-05	0.000295	CcSEcCtD
Bexarotene—Dyspnoea—Etoposide—peripheral nervous system neoplasm	1.81e-05	0.000295	CcSEcCtD
Bexarotene—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	1.81e-05	0.000294	CcSEcCtD
Bexarotene—Somnolence—Etoposide—peripheral nervous system neoplasm	1.81e-05	0.000294	CcSEcCtD
Bexarotene—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	0.000294	CcSEcCtD
Bexarotene—Asthenia—Vincristine—peripheral nervous system neoplasm	1.8e-05	0.000293	CcSEcCtD
Bexarotene—Pneumonia—Epirubicin—peripheral nervous system neoplasm	1.8e-05	0.000292	CcSEcCtD
Bexarotene—Vomiting—Dactinomycin—peripheral nervous system neoplasm	1.78e-05	0.000291	CcSEcCtD
Bexarotene—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	1.78e-05	0.00029	CcSEcCtD
Bexarotene—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	1.78e-05	0.00029	CcSEcCtD
Bexarotene—Rash—Dactinomycin—peripheral nervous system neoplasm	1.77e-05	0.000288	CcSEcCtD
Bexarotene—Decreased appetite—Etoposide—peripheral nervous system neoplasm	1.77e-05	0.000288	CcSEcCtD
Bexarotene—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	1.76e-05	0.000287	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	1.75e-05	0.000286	CcSEcCtD
Bexarotene—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	1.75e-05	0.000285	CcSEcCtD
Bexarotene—Fatigue—Etoposide—peripheral nervous system neoplasm	1.75e-05	0.000285	CcSEcCtD
Bexarotene—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.000285	CcSEcCtD
Bexarotene—Jaundice—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.000283	CcSEcCtD
Bexarotene—Stomatitis—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.000283	CcSEcCtD
Bexarotene—Constipation—Etoposide—peripheral nervous system neoplasm	1.74e-05	0.000283	CcSEcCtD
Bexarotene—Pain—Etoposide—peripheral nervous system neoplasm	1.74e-05	0.000283	CcSEcCtD
Bexarotene—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.000283	CcSEcCtD
Bexarotene—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.000283	CcSEcCtD
Bexarotene—Dysuria—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	0.000282	CcSEcCtD
Bexarotene—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	0.000282	CcSEcCtD
Bexarotene—Dizziness—Alitretinoin—peripheral nervous system neoplasm	1.72e-05	0.00028	CcSEcCtD
Bexarotene—Diarrhoea—Vincristine—peripheral nervous system neoplasm	1.72e-05	0.000279	CcSEcCtD
Bexarotene—Sweating—Epirubicin—peripheral nervous system neoplasm	1.71e-05	0.000279	CcSEcCtD
Bexarotene—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	1.71e-05	0.000279	CcSEcCtD
Bexarotene—Haematuria—Epirubicin—peripheral nervous system neoplasm	1.7e-05	0.000277	CcSEcCtD
Bexarotene—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	1.69e-05	0.000275	CcSEcCtD
Bexarotene—Weight increased—Doxorubicin—peripheral nervous system neoplasm	1.69e-05	0.000275	CcSEcCtD
Bexarotene—Epistaxis—Epirubicin—peripheral nervous system neoplasm	1.68e-05	0.000274	CcSEcCtD
Bexarotene—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	1.68e-05	0.000273	CcSEcCtD
Bexarotene—Sinusitis—Epirubicin—peripheral nervous system neoplasm	1.68e-05	0.000273	CcSEcCtD
Bexarotene—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	1.67e-05	0.000273	CcSEcCtD
Bexarotene—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000272	CcSEcCtD
Bexarotene—Nausea—Dactinomycin—peripheral nervous system neoplasm	1.67e-05	0.000272	CcSEcCtD
Bexarotene—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	1.66e-05	0.000271	CcSEcCtD
Bexarotene—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	1.66e-05	0.000271	CcSEcCtD
Bexarotene—Dizziness—Vincristine—peripheral nervous system neoplasm	1.66e-05	0.00027	CcSEcCtD
Bexarotene—Vomiting—Alitretinoin—peripheral nervous system neoplasm	1.65e-05	0.000269	CcSEcCtD
Bexarotene—Rash—Alitretinoin—peripheral nervous system neoplasm	1.64e-05	0.000267	CcSEcCtD
Bexarotene—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	1.64e-05	0.000267	CcSEcCtD
Bexarotene—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	1.63e-05	0.000266	CcSEcCtD
Bexarotene—Headache—Alitretinoin—peripheral nervous system neoplasm	1.63e-05	0.000266	CcSEcCtD
Bexarotene—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000264	CcSEcCtD
Bexarotene—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Jaundice—Doxorubicin—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Rhinitis—Epirubicin—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Abdominal pain—Etoposide—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Body temperature increased—Etoposide—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	1.61e-05	0.000262	CcSEcCtD
Bexarotene—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	1.6e-05	0.000261	CcSEcCtD
Bexarotene—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	1.59e-05	0.00026	CcSEcCtD
Bexarotene—Vomiting—Vincristine—peripheral nervous system neoplasm	1.59e-05	0.00026	CcSEcCtD
Bexarotene—Asthenia—Cisplatin—peripheral nervous system neoplasm	1.59e-05	0.000259	CcSEcCtD
Bexarotene—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	1.59e-05	0.000259	CcSEcCtD
Bexarotene—Sweating—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.000258	CcSEcCtD
Bexarotene—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000258	CcSEcCtD
Bexarotene—Rash—Vincristine—peripheral nervous system neoplasm	1.58e-05	0.000258	CcSEcCtD
Bexarotene—Dermatitis—Vincristine—peripheral nervous system neoplasm	1.58e-05	0.000257	CcSEcCtD
Bexarotene—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000257	CcSEcCtD
Bexarotene—Haematuria—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.000257	CcSEcCtD
Bexarotene—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000257	CcSEcCtD
Bexarotene—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	1.57e-05	0.000256	CcSEcCtD
Bexarotene—Headache—Vincristine—peripheral nervous system neoplasm	1.57e-05	0.000256	CcSEcCtD
Bexarotene—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	1.56e-05	0.000254	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	0.000252	CcSEcCtD
Bexarotene—Nausea—Alitretinoin—peripheral nervous system neoplasm	1.55e-05	0.000252	CcSEcCtD
Bexarotene—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	1.52e-05	0.000247	CcSEcCtD
Bexarotene—Eye disorder—Epirubicin—peripheral nervous system neoplasm	1.5e-05	0.000244	CcSEcCtD
Bexarotene—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	1.5e-05	0.000244	CcSEcCtD
Bexarotene—Tinnitus—Epirubicin—peripheral nervous system neoplasm	1.49e-05	0.000243	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	1.49e-05	0.000243	CcSEcCtD
Bexarotene—Nausea—Vincristine—peripheral nervous system neoplasm	1.49e-05	0.000243	CcSEcCtD
Bexarotene—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	1.49e-05	0.000242	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	1.49e-05	0.000242	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	1.48e-05	0.000242	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	1.48e-05	0.00024	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	1.47e-05	0.00024	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000239	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000238	CcSEcCtD
Bexarotene—Asthenia—Etoposide—peripheral nervous system neoplasm	1.46e-05	0.000237	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000237	CcSEcCtD
Bexarotene—Angiopathy—Epirubicin—peripheral nervous system neoplasm	1.45e-05	0.000237	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	1.45e-05	0.000237	CcSEcCtD
Bexarotene—Chills—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000234	CcSEcCtD
Bexarotene—Pruritus—Etoposide—peripheral nervous system neoplasm	1.44e-05	0.000234	CcSEcCtD
Bexarotene—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	1.43e-05	0.000233	CcSEcCtD
Bexarotene—Alopecia—Epirubicin—peripheral nervous system neoplasm	1.42e-05	0.000231	CcSEcCtD
Bexarotene—Vomiting—Cisplatin—peripheral nervous system neoplasm	1.41e-05	0.00023	CcSEcCtD
Bexarotene—Rash—Cisplatin—peripheral nervous system neoplasm	1.4e-05	0.000228	CcSEcCtD
Bexarotene—Dermatitis—Cisplatin—peripheral nervous system neoplasm	1.4e-05	0.000227	CcSEcCtD
Bexarotene—Malnutrition—Epirubicin—peripheral nervous system neoplasm	1.4e-05	0.000227	CcSEcCtD
Bexarotene—Erythema—Epirubicin—peripheral nervous system neoplasm	1.4e-05	0.000227	CcSEcCtD
Bexarotene—Diarrhoea—Etoposide—peripheral nervous system neoplasm	1.39e-05	0.000226	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	1.39e-05	0.000226	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	1.38e-05	0.000225	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	1.38e-05	0.000224	CcSEcCtD
Bexarotene—Flatulence—Epirubicin—peripheral nervous system neoplasm	1.37e-05	0.000224	CcSEcCtD
Bexarotene—Tension—Epirubicin—peripheral nervous system neoplasm	1.37e-05	0.000223	CcSEcCtD
Bexarotene—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	1.37e-05	0.000223	CcSEcCtD
Bexarotene—Nervousness—Epirubicin—peripheral nervous system neoplasm	1.36e-05	0.000221	CcSEcCtD
Bexarotene—Back pain—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.00022	CcSEcCtD
Bexarotene—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	1.35e-05	0.000219	CcSEcCtD
Bexarotene—Dizziness—Etoposide—peripheral nervous system neoplasm	1.34e-05	0.000219	CcSEcCtD
Bexarotene—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000218	CcSEcCtD
Bexarotene—Chills—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000217	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.32e-05	0.000216	CcSEcCtD
Bexarotene—Nausea—Cisplatin—peripheral nervous system neoplasm	1.32e-05	0.000215	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.31e-05	0.000213	CcSEcCtD
Bexarotene—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	1.29e-05	0.000211	CcSEcCtD
Bexarotene—Vomiting—Etoposide—peripheral nervous system neoplasm	1.29e-05	0.00021	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	0.00021	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	0.00021	CcSEcCtD
Bexarotene—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.29e-05	0.00021	CcSEcCtD
Bexarotene—Agitation—Epirubicin—peripheral nervous system neoplasm	1.28e-05	0.000209	CcSEcCtD
Bexarotene—Rash—Etoposide—peripheral nervous system neoplasm	1.28e-05	0.000209	CcSEcCtD
Bexarotene—Dermatitis—Etoposide—peripheral nervous system neoplasm	1.28e-05	0.000208	CcSEcCtD
Bexarotene—Headache—Etoposide—peripheral nervous system neoplasm	1.27e-05	0.000207	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—peripheral nervous system neoplasm	1.27e-05	0.000207	CcSEcCtD
Bexarotene—Tension—Doxorubicin—peripheral nervous system neoplasm	1.27e-05	0.000206	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	1.26e-05	0.000206	CcSEcCtD
Bexarotene—Malaise—Epirubicin—peripheral nervous system neoplasm	1.26e-05	0.000205	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.000204	CcSEcCtD
Bexarotene—Vertigo—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.000204	CcSEcCtD
Bexarotene—Syncope—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.000204	CcSEcCtD
Bexarotene—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.000203	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.000203	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000202	CcSEcCtD
Bexarotene—Palpitations—Epirubicin—peripheral nervous system neoplasm	1.23e-05	0.000201	CcSEcCtD
Bexarotene—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	1.23e-05	0.0002	CcSEcCtD
Bexarotene—Cough—Epirubicin—peripheral nervous system neoplasm	1.22e-05	0.000198	CcSEcCtD
Bexarotene—Nausea—Etoposide—peripheral nervous system neoplasm	1.21e-05	0.000197	CcSEcCtD
Bexarotene—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.2e-05	0.000196	CcSEcCtD
Bexarotene—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	1.2e-05	0.000195	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.19e-05	0.000194	CcSEcCtD
Bexarotene—Arthralgia—Epirubicin—peripheral nervous system neoplasm	1.19e-05	0.000193	CcSEcCtD
Bexarotene—Chest pain—Epirubicin—peripheral nervous system neoplasm	1.19e-05	0.000193	CcSEcCtD
Bexarotene—Myalgia—Epirubicin—peripheral nervous system neoplasm	1.19e-05	0.000193	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—peripheral nervous system neoplasm	1.19e-05	0.000193	CcSEcCtD
Bexarotene—Anxiety—Epirubicin—peripheral nervous system neoplasm	1.18e-05	0.000193	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	1.18e-05	0.000192	CcSEcCtD
Bexarotene—Discomfort—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.000191	CcSEcCtD
Bexarotene—Malaise—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.00019	CcSEcCtD
Bexarotene—Dry mouth—Epirubicin—peripheral nervous system neoplasm	1.16e-05	0.000189	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000189	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000189	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000188	CcSEcCtD
Bexarotene—Confusional state—Epirubicin—peripheral nervous system neoplasm	1.15e-05	0.000187	CcSEcCtD
Bexarotene—Palpitations—Doxorubicin—peripheral nervous system neoplasm	1.14e-05	0.000186	CcSEcCtD
Bexarotene—Oedema—Epirubicin—peripheral nervous system neoplasm	1.14e-05	0.000185	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	1.13e-05	0.000185	CcSEcCtD
Bexarotene—Infection—Epirubicin—peripheral nervous system neoplasm	1.13e-05	0.000184	CcSEcCtD
Bexarotene—Cough—Doxorubicin—peripheral nervous system neoplasm	1.13e-05	0.000183	CcSEcCtD
Bexarotene—Shock—Epirubicin—peripheral nervous system neoplasm	1.12e-05	0.000182	CcSEcCtD
Bexarotene—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	1.12e-05	0.000182	CcSEcCtD
Bexarotene—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.11e-05	0.000182	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—peripheral nervous system neoplasm	1.11e-05	0.000182	CcSEcCtD
Bexarotene—Tachycardia—Epirubicin—peripheral nervous system neoplasm	1.11e-05	0.000181	CcSEcCtD
Bexarotene—Skin disorder—Epirubicin—peripheral nervous system neoplasm	1.11e-05	0.00018	CcSEcCtD
Bexarotene—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	1.1e-05	0.000179	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000179	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000179	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000179	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000178	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	1.09e-05	0.000178	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—peripheral nervous system neoplasm	1.09e-05	0.000177	CcSEcCtD
Bexarotene—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.09e-05	0.000177	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	1.07e-05	0.000175	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—peripheral nervous system neoplasm	1.06e-05	0.000173	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—peripheral nervous system neoplasm	1.05e-05	0.000172	CcSEcCtD
Bexarotene—Infection—Doxorubicin—peripheral nervous system neoplasm	1.05e-05	0.00017	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	1.04e-05	0.000169	CcSEcCtD
Bexarotene—Shock—Doxorubicin—peripheral nervous system neoplasm	1.04e-05	0.000169	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	1.03e-05	0.000168	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.03e-05	0.000168	CcSEcCtD
Bexarotene—Insomnia—Epirubicin—peripheral nervous system neoplasm	1.03e-05	0.000168	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.03e-05	0.000167	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	1.02e-05	0.000167	CcSEcCtD
Bexarotene—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	1.02e-05	0.000167	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	1.02e-05	0.000166	CcSEcCtD
Bexarotene—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	1.02e-05	0.000165	CcSEcCtD
Bexarotene—Somnolence—Epirubicin—peripheral nervous system neoplasm	1.01e-05	0.000165	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1e-05	0.000164	CcSEcCtD
Bexarotene—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	1e-05	0.000163	CcSEcCtD
Bexarotene—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.9e-06	0.000161	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.83e-06	0.00016	CcSEcCtD
Bexarotene—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.82e-06	0.00016	CcSEcCtD
Bexarotene—Pain—Epirubicin—peripheral nervous system neoplasm	9.74e-06	0.000159	CcSEcCtD
Bexarotene—Constipation—Epirubicin—peripheral nervous system neoplasm	9.74e-06	0.000159	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.6e-06	0.000156	CcSEcCtD
Bexarotene—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.53e-06	0.000155	CcSEcCtD
Bexarotene—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.46e-06	0.000154	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.39e-06	0.000153	CcSEcCtD
Bexarotene—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.38e-06	0.000153	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.37e-06	0.000153	CcSEcCtD
Bexarotene—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.31e-06	0.000152	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.28e-06	0.000151	CcSEcCtD
Bexarotene—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.16e-06	0.000149	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.1e-06	0.000148	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.08e-06	0.000148	CcSEcCtD
Bexarotene—Pain—Doxorubicin—peripheral nervous system neoplasm	9.01e-06	0.000147	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.01e-06	0.000147	CcSEcCtD
Bexarotene—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9e-06	0.000147	CcSEcCtD
Bexarotene—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9e-06	0.000147	CcSEcCtD
Bexarotene—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.68e-06	0.000141	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.62e-06	0.00014	CcSEcCtD
Bexarotene—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.39e-06	0.000137	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.33e-06	0.000136	CcSEcCtD
Bexarotene—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.33e-06	0.000136	CcSEcCtD
Bexarotene—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.17e-06	0.000133	CcSEcCtD
Bexarotene—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.06e-06	0.000131	CcSEcCtD
Bexarotene—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.79e-06	0.000127	CcSEcCtD
Bexarotene—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.76e-06	0.000126	CcSEcCtD
Bexarotene—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.56e-06	0.000123	CcSEcCtD
Bexarotene—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.53e-06	0.000123	CcSEcCtD
Bexarotene—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.45e-06	0.000121	CcSEcCtD
Bexarotene—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.24e-06	0.000118	CcSEcCtD
Bexarotene—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.21e-06	0.000117	CcSEcCtD
Bexarotene—Rash—Epirubicin—peripheral nervous system neoplasm	7.18e-06	0.000117	CcSEcCtD
Bexarotene—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.17e-06	0.000117	CcSEcCtD
Bexarotene—Headache—Epirubicin—peripheral nervous system neoplasm	7.13e-06	0.000116	CcSEcCtD
Bexarotene—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.97e-06	0.000113	CcSEcCtD
Bexarotene—Nausea—Epirubicin—peripheral nervous system neoplasm	6.76e-06	0.00011	CcSEcCtD
Bexarotene—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.7e-06	0.000109	CcSEcCtD
Bexarotene—Rash—Doxorubicin—peripheral nervous system neoplasm	6.64e-06	0.000108	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.64e-06	0.000108	CcSEcCtD
Bexarotene—Headache—Doxorubicin—peripheral nervous system neoplasm	6.6e-06	0.000107	CcSEcCtD
Bexarotene—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.26e-06	0.000102	CcSEcCtD
